Analysis for CTVA

$12.88 -0.52 (-3.88%)

📈 Growth — 22/30
💰 Profitability — 14/20
🏦 Financial Health — 15/20
💵 Valuation — 12/20
⚠️ Risk — 7/10

Overall Score: 66/100

Summary:

📈 Growth & Financial Trajectory

Across the observed quarters (2024 Q4 to 2026 Q2), Revenues rose from about $3.98B to $6.38B, marking substantial scale expansion despite notable quarterly volatility (the 2025 period saw a peak near $6.46B in Q2 and softer prints in subsequent quarters). Net income progressed from negative in late 2024 to about $1.16B in 2026 Q2, signaling improving profitability.

💰 Margins & Cash Flow

Gross Profit of approximately $3.66B in 2026 Q2 on $6.38B in revenue implies a robust margin (~57%). Operating income remained positive across most quarters (e.g., 2026 Q2). Net cash flow from operating activities has fluctuated, but 2026 Q2 recorded a positive overall cash flow of about $478M, aided by financing inflows ~$1.14B and modest investing outflows.

🛡️ Balance Sheet & Liquidity

Total assets near $41.6B with equity around $25.5B. Current assets ~$16.36B vs current liabilities ~$10.79B yield a healthy current ratio (~1.5x). Liabilities total about $16.24B, with noncurrent liabilities around $5.45B, suggesting solid balance sheet resilience.

⚠️ Key Drivers & Risks

Drivers: Crop protection and seed demand; favorable R&D pipeline supporting volume and pricing.
Risks: Agriculture market cyclicality/weather; earnings volatility and sensitivity to commodity prices/currency.